Sugi Predict

Sugi Predict / Compounds / SCHEMBL2294008

SCHEMBL2294008

SCHEMBL2294008

CC(C)(c1ccc(O)cc1)c1ccc(OP(=O)(O)c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 5/20 0.54
▸ ESR2 Q92731 4/20 0.54
▸ ALDH1A1 P00352 3/20 0.54
▸ CYP3A4 P08684 2/20 0.54
▸ CA12 O43570 1/20 0.51
▸ CA1 P00915 1/20 0.51
▸ CA2 P00918 1/20 0.51
▸ CA4 P22748 1/20 0.51
▸ CA5A P35218 1/20 0.51
▸ CA7 P43166 1/20 0.51
▸ CA9 Q16790 1/20 0.51
▸ CA5B Q9Y2D0 1/20 0.51
▸ AR P10275 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ SLC6A2 P23975 1/20 0.47
▸ SLC6A4 P31645 1/20 0.47
▸ HTR6 P50406 1/20 0.47
▸ ESRRG P62508 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22499731 0.87 CA2 (0.63) ESR1ESR2CA12CA1CA2
SCHEMBL2290182 0.85 ESR1 (0.58) ESR1ESR2ALDH1A1CYP3A4AR
SCHEMBL29034978 0.84 CA12 (0.56) CA12CA1CA2CA4CA5A
Bisphenol A SCHEMBL811003 0.83 ESR1 (0.59) ESR1ESR2ALDH1A1CYP3A4AR
SCHEMBL811002 0.83 ESR1 (0.59) ESR1ESR2ALDH1A1CYP3A4AR
Bisphenol A SCHEMBL1610315 0.83 SRC (0.61) ESR1ESR2ALDH1A1CYP3A4AR
SCHEMBL14023390 0.83 ESR1 (0.59) ESR1ESR2ALDH1A1CYP3A4AR
SCHEMBL19562991 0.82 ALDH1A1 (0.62) ESR1ESR2ALDH1A1CYP3A4AR
Bisphenol A SCHEMBL19873105 0.81 ESR1 (0.66) ESR1ESR2ALDH1A1CYP3A4CA2
Bisphenol A SCHEMBL29461367 0.81 ESR1 (0.66) ESR1ESR2ALDH1A1CYP3A4CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212179-A1 MICRO-SPHERICAL POROUS BIOCOMPATIBLE SCAFFOLDS AND METHODS AND APPARATUS FOR FABRICATING SAME LIU DAVID 2011-09-01 — — US claimed
EP-2344578-A2 MICRO-SPHERICAL POROUS BIOCOMPATIBLE SCAFFOLDS AND METHODS AND APPARATUS FOR FABRICATING SAME Liu, David (US) 2011-07-20 — — EP claimed
WO-2010062678-A2 MICRO-SPHERICAL POROUS BIOCOMPATIBLE SCAFFOLDS AND METHODS AND APPARATUS FOR FABRICATING SAME LIU DAVID (US) 2010-06-03 — — WO claimed
US-11826951-B2 Temperature-controlled multi-material overprinting CELLINK AB (SE) 2023-11-28 — — US disclosed
US-20210069964-A1 TEMPERATURE-CONTROLLED MULTI-MATERIAL OVERPRINTING BICO GROUP AB (SE) 2021-03-11 — — US disclosed
EP-2010597-B1 POROUS POLYMER BLEND STRUCTURES UNIV QUEENSLAND (AU) 2015-06-17 — — EP disclosed
WO-2012094708-A1 BONE GRAFT BIOMATERIAL THE UNIVERSITY OF QUEENSLAND (AU) 2012-07-19 — — WO disclosed
US-8222308-B2 Porous polymer structures THE UNIVERSITY OF QUEENSLAND (AU) 2012-07-17 — — US disclosed
US-8044108-B2 Porous polymer blend structures THE UNIVERSITY OF QUEENSLAND (AU) 2011-10-25 — — US disclosed
US-20110212179-A1 MICRO-SPHERICAL POROUS BIOCOMPATIBLE SCAFFOLDS AND METHODS AND APPARATUS FOR FABRICATING SAME LIU DAVID 2011-09-01 — — US disclosed
EP-2344578-A2 MICRO-SPHERICAL POROUS BIOCOMPATIBLE SCAFFOLDS AND METHODS AND APPARATUS FOR FABRICATING SAME Liu, David (US) 2011-07-20 — — EP disclosed
WO-2003041568-A2 A THREE-DIMENSIONAL MATRIX FOR PRODUCING LIVING TISSUE EQUIVALENTS UNIVERSITY OF MEDICINE & DENTISTRY OF NEW JERSEY (US) 2003-05-22 — — WO disclosed
US-20020182241-A1 Two-dimensional templates fabricated using high-resolution molding processes are bonded to form three-dimensional scaffold structures with closed lumens. THE CHARLES STARK DRAPER LABORATORY, INC. 2002-12-05 — — US disclosed
WO-2002053193-A2 TISSUE ENGINEERING OF THREE-DIMENSIONAL VASCULARIZED USING MICROFABRICATED POLYMER ASSEMBLY TECHNOLOGY THE CHARLES STARK DRAPER LABORATORY, INC. (US) 2002-07-11 — — WO disclosed
EP-1173235-A1 POROUS POLYMER SCAFFOLDS FOR TISSUE ENGINEERING Rutgers, The State University (US) 2002-01-23 — — EP disclosed
US-6337198-B1 A BIODEGRADABLE AND BIOCOMPATIBLE POROUS POLYMER USED IN TISSUE ENGINEERING AND REGENERATION; THE POLYMER HAS A HIGHLY INTERCONNECTED BIMODAL DISTRIBUTION OF OPEN PORE SIZES, HIGH INTERNAL SURFACE AREA, LINEAR ALIGNED PORES ALONG THE WALLS RUTGERS, THE STATE UNIVERSITY 2002-01-08 — — US disclosed
WO-2000062829-A1 POROUS POLYMER SCAFFOLDS FOR TISSUE ENGINEERING RUTGERS, THE STATE UNIVERSITY (US) 2000-10-26 — — WO disclosed
US-6103255-A Porous polymer scaffolds for tissue engineering RUTGERS, THE STATE UNIVERSITY (US) 2000-08-15 — — US disclosed
US-5686091-A Biodegradable foams for cell transplantation THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) 1997-11-11 — — US disclosed
WO-1995026168-A1 DRUG ELUTING BIODEGRADABLE FOAMS FOR CELL TRANSPLANTATION THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) 1995-10-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212179-A1 MICRO-SPHERICAL POROUS BIOCOMPATIBLE SCAFFOLDS AND METHODS AND APPARATUS FOR FABRICATING SAME CD68, KIT, ARG2 ESR1 4037/4885ESR2 2359/4885ALDH1A1 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.